Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

GlycoVaxyn

- PMLiVE

GSK reverses closure of Irish manufacturing facility

But will initially cut staff numbers at Stiefel's Sligo plant by a third

- PMLiVE

GSK expands open-source research project in TB

Opens up compound library and extends data transparency project

GSK partners with Aeras on TB vaccine

Will begin phase II trials in Kenya, India and South Africa

- PMLiVE

Pakistan to use GSK’s Synflorix in national pneumococcal vaccination programme

Company will supply it at 90 per cent discount through the GAVI Alliance

- PMLiVE

GSK discontinues development of Anacor antibiotic

Patients developed resistance to compound during trial

Shionogi-ViiV to file HIV drug dolutegravir for approval

GSK, Pfizer and Shionogi joint venture completes phase III trials programme

- PMLiVE

GSK’s Dr Brett Haumann takes up chief medical officer role at Circassia

Joins as UK biopharma prepares to move lead technology ToleroMune into phase III

- PMLiVE

GSK persuades NICE to reconsider negative Benlysta decision

Decision on lupus drug referred to expert committee following appeal

Kai Gait returns to GSK as digital marketing director

He will be developing digital channel materials and services, built on customer insights

- PMLiVE

GSK’s Olympic doping facility to research personalised medicines after Games

MRC-NIHR Phenome Centre is “phenomenal legacy” from London 2012 says MRC’s Prof John Savill

GSK and other Olympic sponsors may face hacking attack

IT security firm claims ‘hacktivist’ network Anonymous could target websites of London 2012 partners

GSK pay $3bn to settle drug-marketing case

UK drug-maker pleads guilty for promoting a number of drugs in the US off-label

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links